Real-time financial, economic, and global news with market-focused context and analysis.
Coverage spans equities, macroeconomic data, commodities, currencies, technology, politics, and global events—paired with analysis that highlights why each development matters for traders and investors. From breaking headlines to hourly market snapshots and in-depth articles, the News Hub is designed to help you stay informed, oriented, and ahead of market-moving events.
Military tensions between the United States and Iran have intensified following a series of direct strikes exchanged across the Middle East. U.S. Central Command (CENTCOM) reported on Tuesday evening that it successfully intercepted a wave of Iranian missile and drone attacks directed at Kuwait and Bahrain. In response to these incursions, CENTCOM …
CoreWeave's director, Jack D. Cogen, recently executed a substantial sale of Class A Common Stock shares totaling over $29 million. Despite this insider transaction, the company continues to report strong market momentum, coupled with recent announcements regarding significant financing rounds, advanced technology integration, and positive analyst …
Christopher Peetz, the CEO of Mirum Pharmaceuticals, Inc., recently executed a series of stock sales following the exercise of employee options. These actions occurred after the company's shares had seen significant appreciation over the past year. Separately, Mirum announced plans for a major private placement of senior notes and received positive…
A director at Mirum Pharmaceuticals, Inc. executed a sale of company shares totaling $397,700 after an earlier vesting event. This transaction occurred against a backdrop of significant corporate activity, including the announcement of new convertible senior notes and elevated price targets from major research firms regarding its key drug candidate…
Vivek K. Jayaraman, the Chief Operating Officer of CERUS CORP (NASDAQ:CERS), sold common stock valued at $50,001 on May 29, 2026, through a pre-arranged trading plan. This transaction occurred against a backdrop of recent positive financial news, as Cerus Corporation reported first-quarter earnings that surpassed market expectations for both revenu…
Andrew H. Rubenstein, the Chief Executive Officer and President of Accel Entertainment, Inc., executed significant stock sales in June 2026. These transactions were conducted under a prearranged trading plan (Rule 10b5-1). Concurrently, the company reported its Q1 2026 financials, detailing record revenue of $352 million, although earnings per shar…
DBV Technologies has announced the screening of the first participant in its THRIVE Phase 2 clinical trial evaluating the safety and efficacy of the VIASKIN® Peanut Patch in infants aged 6 to 12 months with peanut allergy. This study builds on prior positive results in older children and aims to explore early intervention potential in the youngest …
U.N. Secretary-General Antonio Guterres has presented three distinct options to the U.N. Security Council for maintaining a uniformed U.N. presence in Lebanon after the U.N. Interim Force in Lebanon (UNIFIL) mandate expires at year-end. The proposals, submitted in a letter to the Council, vary in size and capability, and all would support a strengt…
Hostilities flared again in the Gulf region as Kuwait and Bahrain reported missile and drone alerts while the United States fired on a tanker bound for Iran. Explosions were reported near Qeshm Island and maritime traffic through the Strait of Hormuz remains largely halted. Diplomatic efforts between Iran and the United States are reported to have …
Nurix Therapeutics' Chief Legal Officer, Christine Ring, recently sold a significant amount of common stock through an established Rule 10b5-1 trading plan. Simultaneously, the company generated substantial investor interest by presenting promising clinical data for its drug candidates, leading several major analyst firms to revise their ratings an…
R. David Banyard, Jr., the Chief Executive Officer and President of MasterBrand, Inc., recently acquired a block of common stock. This transaction occurred against a backdrop of mixed financial performance for the company in the first quarter of 2026, which fell short of analyst projections. The report details Mr. Banyard's holdings and highlights …
In remarks at the Wall Street Journal’s Global Food Forum, a Bayer representative said the company has no current plans to separate Monsanto despite facing roughly 100,000 Roundup-related lawsuits. Chief Executive Bill Anderson warned that unresolved litigation could halt American production of glyphosate, and the company continues to pursue settle…
The recent transactions involving Matador Resources Co's Senior Vice President and Chief Accounting Officer, Benjamin T. Colodney, alongside the company's operational updates, point to significant strategic activity. Key developments include Mr. Colodney's purchase of shares via his 401(k) plan and a substantial land acquisition in the Delaware Bas…
The recent activity of key executives at RingCentral, Inc. (RNG), including the sale of shares by Chief Accounting Officer Tarun Arora, occurred against a backdrop of strong first-quarter financial reporting. While RNG reported better-than-expected earnings and revenue for Q1 2026, the company's stock experienced an after-hours decline, suggesting …
Vaibhav Agarwal, the Chief Financial Officer of RingCentral, Inc. (NASDAQ:RNG), recently executed notable stock transactions involving both sales and grants of common stock. These actions occurred while the company reported strong financial results for the first quarter of 2026. The Q1 report showed that RingCentral surpassed market expectations in…
Simrat Randhawa, Executive Vice President and Head of Research & Development at Dianthus Therapeutics, Inc., executed a transaction involving the sale of approximately $2.4 million worth of company common stock on June 1, 2026. These sales were conducted under a pre-arranged Rule 10b5-1 trading plan following the exercise of stock options. The arti…
Mark Coleman, a director at Axsome Therapeutics, Inc., recently executed multiple sales totaling 17,537 shares of common stock, valued at approximately $4.02 million. These sales, which occurred between May 29 and June 2, 2026, were conducted under an established trading plan. The activity takes place as AXSM stock trades near its historical highs,…
A director of Star Equity Holdings purchased additional shares of common stock in late May 2026. This transaction occurs against a backdrop of ongoing corporate activities, including an At Market Issuance Sales Agreement for preferred stock, updated executive compensation plans, and the completion of a significant sale-leaseback transaction involvi…
Alignment Healthcare, Inc. (NASDAQ:ALHC) saw its President - MSO, Mark D. Kent, acquire a significant block of common stock in early June 2026. This transaction occurred alongside the release of robust first-quarter 2026 financial results and several key leadership appointments at the company, suggesting internal confidence amid operational growth.
Zenas BioPharma announced positive Phase 3 INDIGO trial results for obexelimab in treating Immunoglobulin G4-Related Disease (IgG4-RD). The trial met its primary and all key secondary endpoints with statistically significant reductions in disease flare risk, glucocorticoid use, and related toxicities. Obexelimab demonstrated a favorable safety prof…
China's prolonged real estate downturn has moved beyond developers to strike the property services sector. Management firms are facing a crisis as homeowners refuse to pay administrative fees due to falling property values or financial hardship. This lack of revenue is forcing major providers to withdraw from contracts, leaving residential compound…
Phibro Animal Health Corp. director E. Thomas Corcoran recently acquired 10,000 shares of the company's Class A Common Stock on May 29, 2026, valued at $317,700. This transaction occurred while the stock was trading down significantly over the past week. The purchase comes against a backdrop where the firm reported strong financial results for the …
Apollo Global Management announced the completion of the sale of its interest in ALTEMIRA Holdings Co., Ltd., a leading pan-Asian aluminum packaging company, to funds managed by MBK Partners. ALTEMIRA, established through consolidation of former aluminum businesses of Showa Denko and Mitsubishi Materials, operates a vertically integrated aluminum r…
The recent activity of DuPont de Nemours, Inc. (NYSE:DD) CEO Lori Koch involving the sale of company common stock is occurring against a backdrop of significant corporate positive developments for DuPont. Ms. Koch executed two separate transactions in May and June 2026. Concurrently, the company reported strong first-quarter results that exceeded a…
Teresa Briggs, a director at DocuSign, Inc., executed multiple stock transactions in May and June 2026. She sold shares pursuant to a Rule 10b5-1 plan and simultaneously acquired shares resulting from the vesting of Restricted Stock Units (RSUs). Separately, she was granted additional RSUs. The company continues to announce significant technologica…
